YAVAPFMC
TEVA icon

Yahav Achim Ve Achayot - Provident Funds Management Company’s Teva Pharmaceuticals TEVA Stock Holding History

Yahav Achim Ve Achayot - Provident Funds Management Company’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.19M Buy
+35,000
New +$1.17M 0.82% 29

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Yahav Achim Ve Achayot - Provident Funds Management Company's TEVA Position: Q2 2026 in Review

Yahav Achim Ve Achayot - Provident Funds Management Company opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 35,000 shares worth $1.19M. The stake represents 0.82% of the portfolio and ranks #29 among its holdings.

399 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Yahav Achim Ve Achayot - Provident Funds Management Company held 35,000 shares of Teva Pharmaceuticals worth $1.19M as of Q2 2026.
  • Teva Pharmaceuticals was a new Yahav Achim Ve Achayot - Provident Funds Management Company position in Q2 2026.
  • Teva Pharmaceuticals made up 0.82% of Yahav Achim Ve Achayot - Provident Funds Management Company's portfolio in Q2 2026, its #29 holding.
  • 399 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Yahav Achim Ve Achayot - Provident Funds Management Company's 13F filing for Q2 2026, filed 21 Jul 2026.